SCHEMBL30873296

SCHEMBL30873296

CSc1nc(NC2(C)CC2)ncc1Br

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
MAPK8 P45983 2/20 0.33
MAPK9 P45984 2/20 0.33
PIM1 P11309 1/20 0.31
PIM2 Q9P1W9 1/20 0.31
KDR P35968 3/20 0.30
CHEK1 O14757 1/20 0.30
AURKA O14965 1/20 0.30
DAPK3 O43293 1/20 0.30
PRKD3 O94806 1/20 0.30
MAP4K4 O95819 1/20 0.30
LCK P06239 1/20 0.30
FYN P06241 1/20 0.30
CSF1R P07333 1/20 0.30
RET P07949 1/20 0.30
IGF1R P08069 1/20 0.30
PDGFRB P09619 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13734497 1.00 HDAC3 (0.38) HDAC3HDAC1HDAC2HDAC6MAPK8
SCHEMBL13735754 0.79 HDAC3 (0.40) HDAC3HDAC1HDAC2HDAC6MAPK8
SCHEMBL14658072 0.78 POLB (0.39) HDAC3HDAC1HDAC2HDAC6MAPK8
SCHEMBL14657149 0.76 MAPK8 (0.51) HDAC3HDAC1HDAC2HDAC6MAPK8
SCHEMBL23195809 0.72 IGF1R (0.40) KDRIGF1RCLK4CDK1CDK2
SCHEMBL13734929 0.72 CDK1 (0.38) KDRLRRK2CDK1CDK2
SCHEMBL14658958 0.68 GSK3A (0.47) MAPK8MAPK9GSK3AGSK3B
SCHEMBL13734480 0.68 GSK3A (0.47) MAPK8MAPK9GSK3AGSK3B
SCHEMBL3450501 0.67 HDAC3 (0.44) HDAC3HDAC1HDAC2HDAC6KDR
SCHEMBL4584347 0.67 IGF1R (0.48) KDRIGF1RGSK3BALKCDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111471021-B Substituted diamino carboxamides and diamino carbonitrile pyrimidines, compositions thereof, and methods of treatment therewith 西格诺药品有限公司 2024-04-02 CN disclosed